Richard Chia-Yuan Chang

Dr. Richard Chia-Yuan Chang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Molecular Genetics and Metabolism
Verified
Journal Article
Open access
MSMariella T. Simon
Mariella T. Simon
SEShaya S. Eftekharian
Shaya S. Eftekharian
ASAlexander E. Stover
Alexander E. Stover
AOAaron F. Osborne
Aaron F. Osborne
BBBruce H. Braffman
Bruce H. Braffman
JAJose E Abdenur
Jose E Abdenur
Primary mitochondrial complex I deficiency is the most common defect of the mitochondrial respiratory chain. It is caused by defects in structural components and assembly factors of this large protein complex. Mutations in the assembly factor NDUFAF5 are rare, with only five families reported to date. This study provides clinical, biochemical, molecular and functional data for four unrelated additional families, and three novel pathogenic variants. Three cases presented in infancy with lactic acidosis and classic Leigh syndrome. One patient, however, has a milder phenotype, with symptoms starting at 27 months and a protracted clinical course with improvement and relapsing episodes. She is homozygous for a previously reported mutation, p.Met279Arg and alive at 19 years with mild neurological involvement, normal lactate but abnormal urine organic acids. We found the same mutation in one of our severely affected patients in compound heterozygosity with a novel p.Lys52Thr mutation. Both patients with p.Met279Arg are of Taiwanese descent and had severe hyponatremia. Our third and fourth patients, both Caucasian, shared a common, newly described, missense mutation p.Lys109Asn which we show induces skipping of exon 3. Both Caucasian patients were compound heterozygotes, one with a previously reported Ashkenazi founder mutation while the other was negative for additional exonic variants. Whole genome sequencing followed by RNA studies revealed a novel deep intronic variant at position c.223-907A>C inducing an exonic splice enhancer. Our report adds significant new information to the mutational spectrum of NDUFAF5, further delineating the phenotypic heterogeneity of this mitochondrial defect.

26 August 2022 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
EFElisabetta Flex
Elisabetta Flex
SAShahad Albadri
Shahad Albadri
FRFrancesca Clementina Radio
Francesca Clementina Radio
SCSerena Cecchetti
Serena Cecchetti
ALAntonella Lauri
Antonella Lauri
MTMarco Tartaglia
Marco Tartaglia
Kinesins are motor proteins involved in microtubule (MT)-mediated intracellular transport. They contribute to key cellular processes, including intracellular trafficking, organelle dynamics and cell division. Pathogenic variants in kinesin-encoding genes underlie several human diseases characterized by an extremely variable clinical phenotype, ranging from isolated neurodevelopmental/neurodegenerative disorders to syndromic phenotypes belonging to a family of conditions collectively termed as ‘ciliopathies.’ Among kinesins, kinesin-1 is the most abundant MT motor for transport of cargoes towards the plus end of MTs. Three kinesin-1 heavy chain isoforms exist in mammals. Different from KIF5A and KIF5C, which are specifically expressed in neurons and established to cause neurological diseases when mutated, KIF5B is an ubiquitous protein. Three de novo missense KIF5B variants were recently described in four subjects with a syndromic skeletal disorder characterized by kyphomelic dysplasia, hypotonia and DD/ID. Here, we report three dominantly acting KIF5B variants (p.Asn255del, p.Leu498Pro and p.Leu537Pro) resulting in a clinically wide phenotypic spectrum, ranging from dilated cardiomyopathy with adult-onset ophthalmoplegia and progressive skeletal myopathy to a neurodevelopmental condition characterized by severe hypotonia with or without seizures. In vitro and in vivo analyses provide evidence that the identified disease-associated KIF5B variants disrupt lysosomal, autophagosome and mitochondrial organization, and impact cilium biogenesis. All variants, and one of the previously reported missense changes, were shown to affect multiple developmental processes in zebrafish. These findings document pleiotropic consequences of aberrant KIF5B function on development and cell homeostasis, and expand the phenotypic spectrum resulting from altered kinesin-mediated processes.

26 June 2024 in Genes
Verified
Journal Article
Open access
PDF file
CBCarlos Francisco Mares Beltran
Carlos Francisco Mares Beltran
CTChristina Gayle Tise
Christina Gayle Tise
RBRebekah Barrick
Rebekah Barrick
ANAnnie D. Niehaus
Annie D. Niehaus
RSRebecca Sponberg
Rebecca Sponberg
JAJose E Abdenur
Jose E Abdenur
The state of California (CA) added X-linked adrenoleukodystrophy (X-ALD) to newborn screening (NBS) in 2016 via the measurement of C26:0-lysophosphatidylcholine (C26:0-LPC) in a two-tier fashion, followed by sequencing of the ABCD1 gene. This has resulted in the identification of individuals with genetic conditions beyond X-ALD that can also result in elevated C26:0-LPC by NBS. We describe the biochemical, molecular, and clinical characteristics of nine patients from two metabolic centers in California who screened positive by NBS for elevated C26:0-LPC between 2016 and 2022 and were ultimately diagnosed with a genetic condition other than X-ALD. Seven individuals were diagnosed with Zellweger spectrum disorder (ZSD) due to biallelic variants in PEX genes. One male was diagnosed with Klinefelter syndrome and one female was found to have an X chromosome contiguous gene deletion syndrome after the identification of a heterozygous VUS and hemizygous VUS variant in ABCD1, respectively. Patients with ZSD had significantly higher first- and second-tier C26:0-LPC levels compared to the two non-ZSD cases. Identification of children with ZSD and atypical patterns of ABCD1 variants is a secondary benefit of NBS for X-ALD, leading to earlier diagnosis, prompt therapeutic initiation, and more accurate genetic counseling. As screening for X-ALD continues via the measurement of C26:0-LPC, our knowledge of additional genetic conditions associated with elevated C26:0-LPC will continue to advance, allowing for increased recognition of other genetic disorders for which early intervention is warranted.

27 January 2021 in Molecular Genetics and Metabolism Reports
Verified
Journal Article
Open access
MBMonica Boyer
Monica Boyer
JSJanette Skaar
Janette Skaar
MSMary Sowa
Mary Sowa
JTJustin R. Tureson
Justin R. Tureson
CCCristel C. Chapel-Crespo
Cristel C. Chapel-Crespo
RCRichard Chia-Yuan Chang
Richard Chia-Yuan Chang
Phenylalanine hydroxylase (PAH) deficiency is an inborn error of phenylalanine (Phe) metabolism that results in the buildup of dietary Phe to potentially toxic levels. Poorly controlled Phe levels in women of childbearing age are particularly worrisome due to the toxic effect of elevated Phe on fetal development. Pegvaliase was recently approved as an enzyme substitution therapy to reduce Phe concentrations in adult patients with PAH deficiency who have suboptimal Phe control on existing management. During the pegvaliase clinical trials pregnant patients were excluded from participation, but the approved label does not contraindicate its use during pregnancy. This case report describes the outcome of the first PAH deficient patient who elected to continue treatment with pegvaliase during pregnancy and reviews the lessons learned and future considerations.

25 January 2014 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
RWRaymond Wang
Raymond Wang
RCRichard Chia-Yuan Chang
Richard Chia-Yuan Chang
MSMary E. Sowa
Mary E. Sowa
ACAnthony C. Chang
Anthony C. Chang
JAJose E. Abdenur
Jose E. Abdenur

17 July 2026 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Open access
PDF file
KCKristin Cheng
Kristin Cheng
GOGina O'TOole
Gina O'TOole
SCStephanie Chang
Stephanie Chang
RCRichard Chia-Yuan Chang
Richard Chia-Yuan Chang
JMJohn Miklavcic
John Miklavcic
Background: Human milk is considered the gold standard for infant nutrition; however, it is often discontinued in chylothorax and severe very long‐chain acyl‐CoA dehydrogenase (VLCAD) deficiency. As an alternative to complete human milk restriction, defatted human milk may be fed, though it may not fully support optimal infant growth and development. This study aimed to assess the micronutrient profile of defatted human milk. Methods: Human milk was obtained from UCSD Human Milk Research Biorepository (San Diego, CA). Thirty samples representing 10 independent expressions in the morning, afternoon, and evening were pooled for analysis. Fat removal was performed by centrifugation at refrigerated and room temperatures, electric cream separator, and gravity separation. Analyses of macronutrients, micronutrients, fat‐soluble vitamins, and water‐soluble vitamins were conducted in triplicate. Results: All defatting methods decreased vitamins A and E by >80%. Folate decreased most by nonrefrigerated centrifugation (52.3, SD < 0.01%) and least by cream separator (22.8, SD < 0.01%). Zinc decreased most by both nonrefrigerated centrifugation (43.5 ± 0.06%) and cream separator (43.5 ± 0.12%), and least by refrigerated centrifugation (17.7 ± 0.10%). Iodine decreased most by refrigerated centrifugation (40.0, SD < 0.01%) and least by cream separator (31.2, SD < 0.01%). Total triglycerides decreased most by refrigerated centrifugation (87.0 ± 0.03%). Conclusions: All defatting methods decreased amounts of vitamin A, vitamin E, folate, zinc, and iodine. Refrigerated centrifuge was most effective in removing total triglycerides. These results can inform fortification and supplementation guidelines of key micronutrients for patients with chylothorax and VLCAD deficiency consuming defatted human milk.